Search

Your search keyword '"Latorre, M"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Latorre, M" Remove constraint Author: "Latorre, M" Publisher elsevier bv Remove constraint Publisher: elsevier bv
34 results on '"Latorre, M"'

Search Results

1. OC.15.6 DIAGNOSTIC DELAY OF COAELIAC DISEASE IN CHILDHOOD

4. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience

5. Real-life Mepolizumab effectiveness in severe eosinophilic asthmatics with nasal polyposis

6. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

7. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes

10. Factors reducing omalizumab response in severe asthma

11. Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry

12. Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice

13. Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity

15. Neuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: Antioxidant effects

16. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

17. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

28. FRECUENCIA Y CARACTERÍSTICAS DEL CÁNCER COLORRECTAL HEREDITARIO NO POLIPOSIS (CCHNP) Y OTROS CÁNCERES COLORRECTALES NO SINDRÓMICOS EN ESPAÑA. DATOS PRELIMINARES DE UN ESTUDIO POBLACIONAL, PROSPECTIVO Y MULTICÉNTRICO (EPICOLON-II)

33. Factors reducing omalizumab response in severe asthma

34. Erratum to 'Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)' [Gynecol. Oncol. 144 (2017) 396–404]

Catalog

Books, media, physical & digital resources